Indolent diffuse histiocytic lymphoma with sclerosis and chylous effusions.

Abstract:

:A case of diffuse histiocytic lymphoma with sclerosis and chylous pleural and peritoneal effusions spanning four years from onset to diagnosis is presented. Treatment with combination chemotherapy and consolidative radiotherapy resulted in clinical improvement and the patient remains free of disease 14 months after stopping treatment. The problems of chylous effusions and the subgroup of diffuse histiocytic lymphoma with sclerosis are discussed.

journal_name

Cancer

journal_title

Cancer

authors

Hansen RM,Komaki R,Hanson GA,Schlueter DP,Anderson T

doi

10.1002/1097-0142(19830601)51:11<2144::aid-cncr282

subject

Has Abstract

pub_date

1983-06-01 00:00:00

pages

2144-6

issue

11

eissn

0008-543X

issn

1097-0142

journal_volume

51

pub_type

杂志文章

相关文献

CANCER文献大全
  • Proliferating trichilemmal cyst: a simulant of squamous cell carcinoma.

    abstract::Comparison of 50 proliferating trichilemmal cysts with 50 "ordinary" trichilemmal cysts indicated that both types almost invariably occurred on the scalps of women, were diagnosed clinically as cysts, followed a benign course, and featured trichilemmal keratinization. A spectrum was observed from trichilemmal cyst wit...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19810901)48:5<1207::aid-cncr2820

    authors: Brownstein MH,Arluk DJ

    更新日期:1981-09-01 00:00:00

  • Sequelae of treatment in 109 patients followed for 5 to 15 years after diagnosis of sarcoma of the bladder and prostate. A report from the Intergroup Rhabdomyosarcoma Study Committee.

    abstract:BACKGROUND:As increasing numbers of young patients with cancer survive, interest in the late effects of therapy is rising. METHODS:The sequelae of treatment were reviewed after a minimum of 5 years of observation in 109 surviving patients with sarcoma of the bladder or prostate who were enrolled in the Intergroup Rhab...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19930401)71:7<2387::aid-cncr2820

    authors: Raney B Jr,Heyn R,Hays DM,Tefft M,Newton WA Jr,Wharam M,Vassilopoulou-Sellin R,Maurer HM

    更新日期:1993-04-01 00:00:00

  • Restoration of defective EAG-rosetting capacity of cancer patient neutrophils by levamisole.

    abstract::Levamisole, used in vitro at therapeutic concentrations, was found able to restore the defective Fc-receptor activity of cancer patient neutrophils. In addition, the drug prevented the inhibition of normal neutrophils Fc-receptor function by cancer patient sera. The neutrophil Fc-receptor function was also restored in...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19850415)55:8<1668::aid-cncr2820

    authors: Patrone F,Dallegri F,Pistoia V,Ghio R,Sacchetti C

    更新日期:1985-04-15 00:00:00

  • Spinal cord glioma following irradiation for Hodgkin's disease.

    abstract::A 21-year-old patient, after radiation therapy to the mediastinum for Hodgkin's disease, died six years later of a spinal cord glioma, believed to be caused by irradiation therapy. That the x-ray therapy provoked neoplastic changes seems likely, although it could be coincidental. ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19800415)45:8<2051::aid-cncr2820

    authors: Clifton MD,Amromin GD,Perry MC,Abadir R,Watts C,Levy N

    更新日期:1980-04-15 00:00:00

  • The prognostic value of histologic subtypes in primary extremity liposarcoma.

    abstract::Patients with a localized primary liposarcoma of the extremity who were treated in Memorial Sloan-Kettering Cancer Center between 1968 and 1978 were studied. The prognosis of patients with extremity liposarcoma was analyzed according to histopathologic subtypes. A system of five subtypes was used; well-differentiated,...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19891001)64:7<1514::aid-cncr2820

    authors: Chang HR,Hajdu SI,Collin C,Brennan MF

    更新日期:1989-10-01 00:00:00

  • Clinical outcomes and survival surrogacy studies of prostate-specific antigen declines following enzalutamide in men with metastatic castration-resistant prostate cancer previously treated with docetaxel.

    abstract:BACKGROUND:In the AFFIRM trial, enzalutamide significantly increased overall survival (OS) for men with metastatic castration-resistant prostate cancer (mCRPC) after chemotherapy versus placebo and significantly decreased prostate-specific antigen (PSA) levels. The goal of this post hoc analysis was to associate levels...

    journal_title:Cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1002/cncr.30587

    authors: Armstrong AJ,Saad F,Phung,Dmuchowski C,Shore ND,Fizazi K,Hirmand M,Forer D,Scher HI,Bono J

    更新日期:2017-06-15 00:00:00

  • Comparative analysis of the sensitivity of endometrial cancer cells to epidermal growth factor and steroid hormones.

    abstract:BACKGROUND:Epidermal growth factor (EGF) and EGF-regulated processes play an important role in steroid signal transduction. Comparative analysis of EGF and steroid receptor expression and the sensitivity of early stages of proliferation induction, such as activation of phospholipid turnover to EGF and steroids, may pro...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19951215)76:12<2524::aid-cncr282

    authors: Gershtein ES,Shatskaya VA,Kostyleva OI,Ermilova VD,Kushlinsky NE,Krasil'nikov MA

    更新日期:1995-12-15 00:00:00

  • Treatment of advanced bladder carcinoma with irradiation and concomitant 5-fluorouracil infusion.

    abstract::Nineteen patients with locally advanced bladder cancer were treated with irradiation and concomitant 5-fluorouracil intravenous infusion with or without bolus mitomycin. Eighteen of the 19 patients were evaluated for local response. Eleven of the 18 patients (61%) obtained a complete local response within 3 to 6 month...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19870215)59:4<710::aid-cncr28205

    authors: Rotman M,Macchia R,Silverstein M,Aziz H,Choi K,Rosenthal J,Braverman A,Laungani GB

    更新日期:1987-02-15 00:00:00

  • The effects of radiotherapy on immunity in patients with cured localized carcinoma of the cervix uteri.

    abstract::The effects of radiotherapy on immune status in patients with localized carcinoma of the cervix have been assessed serially up to 5 years remission by a wide range of methods. Neutrophil function and serum immunoglobulins were essentially normal throughout. Peripheral blood neutrophil and lymphocyte counts and the pro...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19840215)53:4<884::aid-cncr28205

    authors: Hancock BW,Bruce L,Whitham MD,Ward AM

    更新日期:1984-02-15 00:00:00

  • Malignant mesenchymoma of the bladder.

    abstract::A case of malignant mesenchymoma of the bladder, containing fibroleiomyomatous, myxomatous, osteoid, and cartilaginous components is presented. The primary pedunculated tumor measuring 18 X 10 X 9 cm and weighing 934 g, arose from the anterior wall of the bladder and was treated by partial cystectomy. Six months after...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/1097-0142(19870815)60:4<858::aid-cncr28206

    authors: Terada Y,Saito I,Morohoshi T,Niijima T

    更新日期:1987-08-15 00:00:00

  • Acute lymphoblastic leukemia in adults and children. Differences in response with similar therapeutic regimens.

    abstract::Twenty-three adult patients (ages greater than 15 years) and 75 children with acute lymphoblastic leukemia were treated with similar intensive, sequential cytotoxic protocols (L-2). The adult patients have lower remission rate (78%) than the children (98%). The duration of remission and the length of survival are also...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197603)37:3<1256::aid-cncr282037

    authors: Gee TS,Haghbin M,Dowling MD,Cunningham I,Middleman MP,Clarkson BD

    更新日期:1976-03-01 00:00:00

  • The size of breast masses at presentation. The impact of prior medical training.

    abstract::Five hundred and sixty-nine patients with breast cancer presenting for treatment at a community hospital were studied. The results showed no significant change in tumor size at presentation or reported patient delay over a 12-year span. This was in spite of considerable national discussion and increasing public concer...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19830501)51:9<1750::aid-cncr2820

    authors: Buttlar CA,Templeton AC

    更新日期:1983-05-01 00:00:00

  • The changing landscape of phase II/III metastatic NSCLC clinical trials and the importance of biomarker selection criteria.

    abstract::Over the last decade, new cytotoxic treatments and targeted therapies have altered treatment paradigms for patients with metastatic non-small cell lung cancer (NSCLC). We sought to analyze the impact of histology and biomarker selection criteria on outcomes of clinical trials in metastatic NSCLC reported over the last...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.28956

    authors: Gentzler RD,Yentz SE,Johnson ML,Rademaker AW,Patel JD

    更新日期:2014-12-15 00:00:00

  • Effect of age on the efficacy of adjuvant chemotherapy for resected non-small cell lung cancer.

    abstract:BACKGROUND:Adjuvant chemotherapy after surgical resection improves outcomes for patients with early-stage non-small cell lung cancer (NSCLC). To the authors' knowledge, there are no published prospective trials to date of adjuvant chemotherapy after surgical resection administered exclusively in older patients. In the ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.29360

    authors: Ganti AK,Williams CD,Gajra A,Kelley MJ

    更新日期:2015-08-01 00:00:00

  • Sentinel lymph node versus axillary lymph node dissection for early-stage breast carcinoma: a comparison using a utility-adjusted number needed to treat analysis.

    abstract:BACKGROUND:The current study was performed to compare the value of sentinel lymph node dissection (SND) and axillary lymph node dissection (AND) in improving the utility-adjusted survival for early-stage breast carcinoma patients. METHODS:A number needed to treat (NNT) analysis was used to compare SND with AND. In the...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.11081

    authors: Jani AB,Basu A,Heimann R,Hellman S

    更新日期:2003-01-15 00:00:00

  • Prophylactic glutamine protects the intestinal mucosa from radiation injury.

    abstract::Glutamine may be an essential dietary component, especially for the support of intestinal mucosal growth and function. This study evaluated the effects of a glutamine-enriched elemental diet, administered before whole-abdominal radiation on gut glutamine metabolism, mucosal morphometrics, and bacterial translocation. ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19900701)66:1<62::aid-cncr282066

    authors: Klimberg VS,Souba WW,Dolson DJ,Salloum RM,Hautamaki RD,Plumley DA,Mendenhall WM,Bova FJ,Khan SR,Hackett RL

    更新日期:1990-07-01 00:00:00

  • BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma.

    abstract:BACKGROUND:Uterine serous carcinoma (USC) is not recognized as part of any defined hereditary cancer syndrome, and its association with hereditary breast and ovarian carcinoma and Lynch syndrome are uncertain. METHODS:Using targeted capture and massively parallel genomic sequencing, 151 subjects with USC were assessed...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.27720

    authors: Pennington KP,Walsh T,Lee M,Pennil C,Novetsky AP,Agnew KJ,Thornton A,Garcia R,Mutch D,King MC,Goodfellow P,Swisher EM

    更新日期:2013-01-15 00:00:00

  • Extragonadal germ cell tumors in Taiwan: an analysis of treatment results of 59 patients.

    abstract:BACKGROUND:Extragonadal germ cell tumors (EGCT) are rare. They are biologically distinct from their testicular counterparts. Information regarding these tumors from the Far East is limited. More investigations are warranted to define the optimal treatment. METHODS:Retrospective review of the medical records of 59 pati...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.10738

    authors: Hsu YJ,Pai L,Chen YC,Ho CL,Kao WY,Chao TY

    更新日期:2002-08-15 00:00:00

  • Accumulative increase of loss of heterozygosity from leukoplakia to foci of early cancerization in leukoplakia of the oral cavity.

    abstract:BACKGROUND:Oral leukoplakia is a premalignant lesion, but the genetic changes in the foci of early cancerization in leukoplakia have not been studied. METHODS:Loss of heterozygosity (LOH) was successively investigated in 13 cases in the leukoplakia and foci of early cancerization in the same leukoplakia. The authors m...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(20011101)92:9<2349::aid-cncr1582

    authors: Jiang WW,Fujii H,Shirai T,Mega H,Takagi M

    更新日期:2001-11-01 00:00:00

  • Trichosporon sepsis and leukemia.

    abstract::Trichosporon cutaneum is a fungus known to cause superficial nodules over the distal third of hair shafts, mainly scalp hair, and to produce a clinical entity known as piedra. This superficial mycosis occurs mostly in temperate and tropical regions and is rarely seen in North America. Trichosporon cutaneum spesis is d...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197509)36:3<1106::aid-cncr282036

    authors: Rivera R,Cangir A

    更新日期:1975-09-01 00:00:00

  • Long-term results of a phase 2 trial of nilotinib 400 mg twice daily in newly diagnosed patients with chronic-phase chronic myeloid leukemia.

    abstract:BACKGROUND:Nilotinib is a potent, second-generation inhibitor of BCR-ABL1 tyrosine kinase and has been approved as frontline and salvage therapy for patients with chronic-phase chronic myeloid leukemia (CP-CML). METHODS:In this single-institution, phase 2 study, 122 patients with newly diagnosed CP-CML received niloti...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.32623

    authors: Masarova L,Cortes JE,Patel KP,O'Brien S,Nogueras-Gonzalez GM,Konopleva M,Verstovsek S,Garcia-Manero G,Ferrajoli A,Kadia TM,Ravandi-Kashani F,Borthakur G,DellaSala S,Estrov Z,Jabbour EJ,Kantarjian HM

    更新日期:2020-04-01 00:00:00

  • Evolution of the team approach in breast cancer.

    abstract::Dr. Wendell G. Scott hailed mammography as the first significant contribution to the control of breast cancer since Halsted described the radical mastectomy in 1903. Mammography as engendered new approaches and has supplied new concepts of breast cancer. Through the tenacity of a few physicians convinced something cou...

    journal_title:Cancer

    pub_type: 历史文章,杂志文章

    doi:10.1002/1097-0142(197511)36:5<1815::aid-cncr282036

    authors: Egan RL

    更新日期:1975-11-01 00:00:00

  • Treatment of children with neurogenic sarcoma. Experience at the Children's Hospital of Philadelphia, 1958-1984.

    abstract::Twenty-four children aged 3 months to 18 years (median, 12 years) were treated for neurogenic sarcoma at the Children's Hospital of Philadelphia Cancer Research Center from 1958 through 1984. Sixteen patients had neurofibromatosis (NF). The tumors arose in an extremity or in the trunk (15 patients), the retroperitoneu...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19870101)59:1<1::aid-cncr2820590

    authors: Raney B,Schnaufer L,Ziegler M,Chatten J,Littman P,Jarrett P

    更新日期:1987-01-01 00:00:00

  • Treatment of children with epipodophyllotoxin-induced secondary acute myeloid leukemia.

    abstract:BACKGROUND:Secondary acute myeloid leukemia (AML) after treatment with epipodophyllotoxins is being observed with increased frequency. Therapeutic options are limited for patients with secondary AML and the role of bone marrow transplantation is unclear. METHODS:The authors report the treatment outcome of a cohort of ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19970301)79:5<1049::aid-cn

    authors: Sandler ES,Friedman DJ,Mustafa MM,Winick NJ,Bowman WP,Buchanan GR

    更新日期:1997-03-01 00:00:00

  • The prevalence of patients with colorectal carcinoma under care in the U.S.

    abstract:BACKGROUND:Prevalence usually is defined as the proportion of individuals alive who previously had a diagnosis of the disease, regardless of whether the individuals still are receiving treatment or are cured. The objective of this study was to estimate the proportion of elderly patients with colorectal carcinoma (CRC) ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.11631

    authors: Mariotto A,Warren JL,Knopf KB,Feuer EJ

    更新日期:2003-09-15 00:00:00

  • Cerebrospinal fluid-disseminated meningioma.

    abstract:BACKGROUND:Intracranial meningiomas are common and comprise 20% of all primary brain tumors. Meningiomas infrequently metastasize; however, to the authors' knowledge there are limited data regarding the spread of disease through cerebrospinal fluid (CSF). METHODS:Eight of 200 consecutive patients (4%) with meningiomas...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.20926

    authors: Chamberlain MC,Glantz MJ

    更新日期:2005-04-01 00:00:00

  • The future of cancer screening after COVID-19 may be at home.

    abstract:LAY SUMMARY:During the coronavirus disease 2019 (COVID-19) pandemic, cancer screening decreased precipitously; home screening for colorectal cancer diminished less than that for colonoscopy and breast and cervical cancer screening. The authors have highlighted approaches for home cancer screening in addition to telemed...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.33274

    authors: Gorin SNS,Jimbo M,Heizelman R,Harmes KM,Harper DM

    更新日期:2021-02-15 00:00:00

  • Chemotherapy in patients with recurrent and progressive central neurocytoma.

    abstract:BACKGROUND:Recurrent central neurocytoma is very rare and to the authors' knowledge data regarding its response to chemotherapy currently are not available. METHODS:Three patients with progressive neurocytoma received chemotherapy after their informed consent was obtained. Disease recurred in two patients after surger...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(20000101)88:1<169::aid-cnc

    authors: Brandes AA,Amistà P,Gardiman M,Volpin L,Danieli D,Guglielmi B,Carollo C,Pinna G,Turazzi S,Monfardini S

    更新日期:2000-01-01 00:00:00

  • Lack of trastuzumab activity in nonsmall cell lung carcinoma with overexpression of erb-B2: 39810: a phase II trial of Cancer and Leukemia Group B.

    abstract:BACKGROUND:The overexpression of HER-2 occurs in a minority of patients with nonsmall cell lung carcinoma. Trastuzumab, which is a monoclonal antibody to HER-2, is an effective treatment in some women with breast carcinomas that overexpress HER-2, as demonstrated by immunohistochemistry. The objective of this Phase II ...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1002/cncr.20950

    authors: Clamon G,Herndon J,Kern J,Govindan R,Garst J,Watson D,Green M,Cancer and Leukemia Group B.

    更新日期:2005-04-15 00:00:00

  • Flexible fiberoptic bronchoscopy in metastatic cancer to the lungs.

    abstract::Seventy-eight patients with metastatic cancer to the lungs underwent flexible fiberoptic bronchoscopy for diagnosis. The patients were divided into two groups by presenting radiographic pattern as: (I) diffuse linear interstitial infiltrations (55 patients); and (II) localized or multiple nodular opacities (23 patient...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19831115)52:10<1949::aid-cncr282

    authors: Chuang MT,Padilla ML,Teirstein AS

    更新日期:1983-11-15 00:00:00